Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SLOMSKI A
    Abeta-Clearing Drug Fails to Slow Alzheimer Disease.
    JAMA. 2018;319:2470.
    PubMed     Text format    


    March 2018
  2. ABBASI J
    Plasma Biomarkers Predict Brain Amyloid-beta Burden.
    JAMA. 2018;319:972.
    PubMed     Text format    


    January 2018
  3. ATRI A, Frolich L, Ballard C, Tariot PN, et al
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    JAMA. 2018;319:130-142.
    PubMed     Text format     Abstract available


  4. BENNETT DA
    Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process.
    JAMA. 2018;319:123-125.
    PubMed     Text format    


    October 2017
  5. ABBASI J
    A Retinal Scan for Alzheimer Disease.
    JAMA. 2017;318:1314.
    PubMed     Text format    


  6. DONOHUE MC, Aisen PS
    Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
    JAMA. 2017;318:1393-1394.
    PubMed     Text format    


  7. GAO R, Chen C, Zhu T
    Elevated Brain Amyloid in Cognitively Normal Individuals.
    JAMA. 2017;318:1392-1393.
    PubMed     Text format    


    June 2017
  8. VISSER PJ, Tijms B
    Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?
    JAMA. 2017;317:2285-2287.
    PubMed     Text format    


  9. DONOHUE MC, Sperling RA, Petersen R, Sun CK, et al
    Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    JAMA. 2017;317:2305-2316.
    PubMed     Text format     Abstract available


    May 2017
  10. SABAYAN B, Sorond F
    Reducing Risk of Dementia in Older Age.
    JAMA. 2017;317:2028.
    PubMed     Text format    


    April 2017
  11. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Text format     Abstract available


    February 2017
  12. LYON J
    Alzheimer Outlook Far From Bleak.
    JAMA. 2017 Feb 15. doi: 10.1001/jama.2017.0276.
    PubMed     Text format    


    December 2016
  13. LYON J
    Study Suggests Alzheimer and Parkinson Disease Are Not Transmitted Through Blood Transfusion.
    JAMA. 2016 Dec 21. doi: 10.1001/jama.2016.16260.
    PubMed     Text format    


    March 2016
  14. CUMMINGS JL, Siffert J
    Dextromethorphan-Quinidine for Agitation in Alzheimer Disease--Reply.
    JAMA. 2016;315:1166-7.
    PubMed     Text format    


  15. NEWMAN JC, Steinman MA
    Dextromethorphan-Quinidine for Agitation in Alzheimer Disease.
    JAMA. 2016;315:1166.
    PubMed     Text format    


    February 2016
  16. KROGER E, Laforce R Jr
    Fish Consumption, Brain Mercury, and Neuropathology in Patients With Alzheimer Disease and Dementia.
    JAMA. 2016;315:465-6.
    PubMed     Text format    


  17. MORRIS MC, Brockman J, Schneider JA, Wang Y, et al
    Association of Seafood Consumption, Brain Mercury Level, and APOE epsilon4 Status With Brain Neuropathology in Older Adults.
    JAMA. 2016;315:489-97.
    PubMed     Text format     Abstract available


    January 2016
  18. FELDMAN AM, Haller JA, DeKosky ST
    Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations.
    JAMA. 2016;315:25-6.
    PubMed     Text format    


    September 2015
  19. CUMMINGS JL, Lyketsos CG, Peskind ER, Porsteinsson AP, et al
    Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial.
    JAMA. 2015;314:1242-54.
    PubMed     Text format     Abstract available


  20. BALLARD C, Sharp S, Corbett A
    Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia.
    JAMA. 2015;314:1233-5.
    PubMed     Text format    


  21. JANSEN WJ, Ossenkoppele R, Visser PJ
    Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk--Reply.
    JAMA. 2015;314:1177-8.
    PubMed     Text format    


  22. WAGNER M, Jessen F
    Amyloid Pathology, Cognitive Impairment, and Alzheimer Disease Risk.
    JAMA. 2015;314:1177.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: